Examining FDA's Generic Drug and Biosimilar User Fee Programs: Hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session
Coverage: Washington : U.S. Govt. Print. Off., 2018